Počet záznamov: 1
inhibítory PCSK9
SYS d000091362 LBL 00000cx^^^2200181-^^45^^ 005 20240119195404.0 100 $a 20220101asloy0103 ba0 152 $b mesh 250 $a inhibítory PCSK9 $x AD $x AE $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2022 $8 eng 300 1-
$a Anticholesteremic Agents (2018-2021) $8 eng 330 1-
$a Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level. $8 eng 450 $a PCSK9 Inhibitors Cardiovascular $5 e $8 eng 450 $a PCSK9 Inhibitors, Cardiovascular $5 e $8 eng 450 $a inhibítor PCSK9, kardiovaskulárny $5 e $8 slo 686 $a D27.505.519.186.071.202.685 686 $a D27.505.519.389.745.800.506 686 $a D27.505.954.557.500.202.685 750 $a PCSK9 Inhibitors $8 eng 801 -0
$a SK $b BA006 $c 20220213 801 -2
$a SK $b BA006 $c 20220301 980 $x M
Počet záznamov: 1